Federated Hermes, Inc. Regulus Therapeutics Inc. Transaction History
Federated Hermes, Inc.
- $43.6 Billion
- Q3 2024
A detailed history of Federated Hermes, Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 12,852,654 shares of RGLS stock, worth $19.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,852,654
Previous 12,852,654
-0.0%
Holding current value
$19.3 Million
Previous $23 Million
12.29%
% of portfolio
0.05%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding RGLS
# of Institutions
74Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Nea Management Company, LLC Timonium, MD6.47MShares$9.7 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.5 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.4 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$5.95 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $22M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...